Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1948 2
1949 2
1950 3
1951 12
1952 10
1953 31
1954 28
1955 50
1956 51
1957 73
1958 72
1959 63
1960 55
1961 65
1962 53
1963 93
1964 115
1965 93
1966 136
1967 157
1968 262
1969 331
1970 400
1971 459
1972 512
1973 547
1974 684
1975 733
1976 863
1977 841
1978 853
1979 876
1980 965
1981 918
1982 950
1983 909
1984 986
1985 930
1986 896
1987 872
1988 876
1989 826
1990 812
1991 763
1992 730
1993 745
1994 685
1995 689
1996 673
1997 664
1998 625
1999 592
2000 575
2001 577
2002 636
2003 608
2004 725
2005 715
2006 767
2007 835
2008 940
2009 1063
2010 1157
2011 1314
2012 1496
2013 1661
2014 1888
2015 1920
2016 1920
2017 1970
2018 2093
2019 2161
2020 2306
2021 2505
2022 2451
2023 2577
2024 1624

Text availability

Article attribute

Article type

Publication date

Search Results

56,733 results

Results by year

Filters applied: . Clear all
Page 1
Glucagon Receptor Signaling and Glucagon Resistance.
Janah L, Kjeldsen S, Galsgaard KD, Winther-Sørensen M, Stojanovska E, Pedersen J, Knop FK, Holst JJ, Wewer Albrechtsen NJ. Janah L, et al. Int J Mol Sci. 2019 Jul 5;20(13):3314. doi: 10.3390/ijms20133314. Int J Mol Sci. 2019. PMID: 31284506 Free PMC article. Review.
Glucagon receptor antagonists have indirectly put focus on glucagon's potential role in lipid metabolism, as individuals treated with these antagonists showed dyslipidemia and increased hepatic fat. One emerging field in glucagon biology now seems to i
Glucagon receptor antagonists have indirectly put focus on glucagon's potential role in lipid metabolism, as individual
Glucagon's Metabolic Action in Health and Disease.
Zeigerer A, Sekar R, Kleinert M, Nason S, Habegger KM, Müller TD. Zeigerer A, et al. Compr Physiol. 2021 Apr 1;11(2):1759-1783. doi: 10.1002/cphy.c200013. Compr Physiol. 2021. PMID: 33792899 Free PMC article.
Glucagon further promotes lipolysis and lipid oxidation and has positive chronotropic and inotropic effects in the heart. Interestingly, recent decades have witnessed a remarkable renaissance of glucagon's biology with the acknowledgment that glucagon
Glucagon further promotes lipolysis and lipid oxidation and has positive chronotropic and inotropic effects in the heart. Interesting
100 years of glucagon and 100 more.
Wewer Albrechtsen NJ, Holst JJ, Cherrington AD, Finan B, Gluud LL, Dean ED, Campbell JE, Bloom SR, Tan TM, Knop FK, Müller TD. Wewer Albrechtsen NJ, et al. Diabetologia. 2023 Aug;66(8):1378-1394. doi: 10.1007/s00125-023-05947-y. Epub 2023 Jun 27. Diabetologia. 2023. PMID: 37367959 Review.
This review summarises experiences since the discovery of glucagon regarding basic and clinical aspects of this hormone and speculations on the future directions for glucagon biology and glucagon-based therapies. ...The interplay between the pancreas and the …
This review summarises experiences since the discovery of glucagon regarding basic and clinical aspects of this hormone and speculati …
Glucagon Regulation of Energy Expenditure.
Kleinert M, Sachs S, Habegger KM, Hofmann SM, Müller TD. Kleinert M, et al. Int J Mol Sci. 2019 Oct 30;20(21):5407. doi: 10.3390/ijms20215407. Int J Mol Sci. 2019. PMID: 31671603 Free PMC article. Review.
Glucagon's ability to increase energy expenditure has been known for more than 60 years, yet the mechanisms underlining glucagon's thermogenic effect still remain largely elusive. Over the last years, significant efforts were directed to unravel the ph
Glucagon's ability to increase energy expenditure has been known for more than 60 years, yet the mechanisms underlining glu
Structural Refinement of Glucagon for Therapeutic Use.
Chabenne JR, Mroz PA, Mayer JP, DiMarchi RD. Chabenne JR, et al. J Med Chem. 2020 Apr 9;63(7):3447-3460. doi: 10.1021/acs.jmedchem.9b01493. Epub 2019 Dec 18. J Med Chem. 2020. PMID: 31774682 Review.
Glucagon counters insulin's effects on glucose metabolism and serves as a rescue medicine in the treatment of hypoglycemia. ...These advances have indirectly promoted the integrated use of glucagon agonism with other hormones in a manner that runs counter to the lon
Glucagon counters insulin's effects on glucose metabolism and serves as a rescue medicine in the treatment of hypoglycemia. ...These
Hepatic glucagon action: beyond glucose mobilization.
Kajani S, Laker RC, Ratkova E, Will S, Rhodes CJ. Kajani S, et al. Physiol Rev. 2024 Jul 1;104(3):1021-1060. doi: 10.1152/physrev.00028.2023. Epub 2024 Feb 1. Physiol Rev. 2024. PMID: 38300523 Review.
Glucagon's ability to promote hepatic glucose production has been known for over a century, with initial observations touting this hormone as a diabetogenic agent. ...However, growing evidence, in part thanks to new and sensitive "omics" technologies, has implicated
Glucagon's ability to promote hepatic glucose production has been known for over a century, with initial observations touting
Glucagon: Delivery advancements for hypoglycemia management.
Kumar S, Sanap SN, Pandey P, Khopade A, Sawant KK. Kumar S, et al. Int J Pharm. 2024 Mar 5;652:123785. doi: 10.1016/j.ijpharm.2024.123785. Epub 2024 Jan 13. Int J Pharm. 2024. PMID: 38224759 Review.
As the 100th anniversary of glucagon's discovery approaches, we reflect on the remarkable journey of understanding its pivotal role in glucose regulation. ...Finally, this review will help the formulation scientist, clinicians, healthcare providers, and patient to m …
As the 100th anniversary of glucagon's discovery approaches, we reflect on the remarkable journey of understanding its pivotal …
Glucagon.
Downes MA. Downes MA. Emerg Med (Fremantle). 2003 Oct-Dec;15(5-6):480-5. doi: 10.1046/j.1442-2026.2003.00506.x. Emerg Med (Fremantle). 2003. PMID: 14992065 Review.
Despite its infrequent usage, glucagon is an important drug in the ED. It has both well established and less well established indications. ...
Despite its infrequent usage, glucagon is an important drug in the ED. It has both well established and less well established indicat …
Stable Liquid Glucagon: Beyond Emergency Hypoglycemia Rescue.
Wilson LM, Castle JR. Wilson LM, et al. J Diabetes Sci Technol. 2018 Jul;12(4):847-853. doi: 10.1177/1932296818757795. Epub 2018 Feb 8. J Diabetes Sci Technol. 2018. PMID: 29415555 Free PMC article. Review.
Better formulations and devices for glucagon treatment of hypoglycemia are needed, specifically stable liquid glucagon. ...In the 35 years since Food and Drug Administration (FDA) approval of the first liquid stable human recombinant insulin, we continue to wait for …
Better formulations and devices for glucagon treatment of hypoglycemia are needed, specifically stable liquid glucagon. ...In …
Glucagon.
Foà PP. Foà PP. Ergeb Physiol. 1968;60:141-219. doi: 10.1007/BFb0107253. Ergeb Physiol. 1968. PMID: 4298671 Review. No abstract available.
56,733 results
You have reached the last available page of results. Please see the User Guide for more information.